SCHEMBL30658269

SCHEMBL30658269

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C)[C@@H](C)O)C(C)C

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 3/20 0.68
▸ GLP1R P43220 14/20 0.66
▸ CCKBR P32239 1/20 0.66
▸ PTH1R Q03431 1/20 0.65
▸ KEAP1 Q14145 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30658350 0.95 GLP1R (0.66) CALCRGLP1RCCKBRPTH1RKEAP1
SCHEMBL31182893 0.95 PTH1R (0.67) CALCRGLP1RCCKBRPTH1RKEAP1
SCHEMBL30518506 0.93 GLP1R (0.74) GLP1RCCKBR
SCHEMBL30358210 0.93 GLP1R (0.74) GLP1RCCKBR
SCHEMBL30422899 0.93 GLP1R (0.72) GLP1RCCKBRPTH1RKEAP1
SCHEMBL30358209 0.93 GLP1R (0.74) GLP1RCCKBR
SCHEMBL30657454 0.92 GLP1R (0.75) GLP1RCCKBRPTH1R
SCHEMBL31099253 0.92 GLP1R (0.76) GLP1RCCKBRPTH1R
SCHEMBL30644874 0.92 GLP1R (0.72) GLP1RCCKBR
SCHEMBL31182687 0.92 GLP1R (0.69) GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753627-B2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-09-12 — — US disclosed
Send feedback